Catalyst Health Economics Consultants

Vaccines

A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac® in the UK.

Authors: R Das Gupta & JF Guest.
Source: Pharmacoeconomics 2002; 20(7): 475-484.

View Abstract


<<< Go Back

Catalyst Health Economics Consultants Ltd
© 1991 - 2009